Babies' Brain Responses to Strangers
Launched by UNIVERSITY OF CALIFORNIA SANTA CRUZ · Aug 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how infants understand and react to faces of people from different racial backgrounds. Researchers want to see if babies pay more attention to faces of people who look like them (their racial group) compared to those who look different. They will also gather information about the racial diversity in the babies' surroundings, such as their families and neighborhoods, to better understand how these factors influence their social development.
The study is looking for infants who are between 8 to 11 months old and are typically developing, meaning they have no known delays in their growth or learning. If your baby was born after at least 37 weeks of pregnancy and meets these criteria, they may be eligible to participate. During the trial, babies will participate in activities designed to measure their attention and reactions to different faces. This is a great opportunity to contribute to important research that could help us understand how infants develop social skills in a diverse world.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • typically developing
- • age 7 to 12 months
- • at least 37 weeks gestation
- Exclusion Criteria:
- • any known developmental delays
- • less than 37 weeks gestation
About University Of California Santa Cruz
The University of California, Santa Cruz (UCSC) is a leading research institution dedicated to advancing scientific knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UCSC leverages its diverse expertise in fields such as biology, psychology, and health sciences to conduct cutting-edge research. The university's clinical trial initiatives focus on addressing pressing health challenges, fostering the translation of research findings into effective interventions, and enhancing patient care. Committed to ethical standards and community engagement, UCSC strives to contribute meaningful advancements in medical science and to promote the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Cruz, California, United States
Patients applied
Trial Officials
Hyesung Hwang, PhD
Principal Investigator
University of California Santa Cruz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported